Next-generation biomaterial being developed to treat bleeding


Researchers at Mayo Clinic (Rochester, USA), Harvard Medical School and the Massachusetts Institute of Technology (both Boston, USA) are developing a biomaterial that has potential to protect patients at high risk for bleeding in surgery.

Embolization is often accomplished by inserting metallic coils through a catheter into a vessel, which induces clotting to prevent further bleeding.

Rahmi Oklu, a vascular interventional radiologist at Mayo Clinic’s Arizona campus, explains shear-thinning biomaterial offers many advantages over metallic coils.